Immune-based Therapies for Hematological Malignancies: An Update by the EHA SWG on Immunotherapy of Hematological Malignancies-Reference-Cited by-同舟云学术

Immune-based Therapies for Hematological Malignancies: An Update by the EHA SWG on Immunotherapy of Hematological Malignancies

Published:2020-06-29 Issue:4 Volume:4 Page:e423
ISSN:2572-9241
Container-title:HemaSphere
language:en
Short-container-title:

Author:

Einsele Hermann,Briones Javier,Ciceri Fabio,García-Cadenas Irene,Falkenburg Fred,Bolaños Natacha,Heemskerk H.M. Mirjam,Houot Roch,Hudecek Michael,Locatelli Franco,Morgan Kate,Morris C. Emma,O’Dwyer Michael,Gil Jordi Sierra,van den Brink Marcel,van de Loosdrecht Arjan A.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Hematology

Reference53 articles.

1. Building better monoclonal antibody-based therapeutics;Weiner;Nat Rev Cancer.,2015

2. Opportunities for therapeutic antibodies directed at G-protein-coupled receptors;Hutchings;Nat Rev Drug Discov.,2017

3. Monoclonal antibodies: technologies for early discovery and engineering;Kennedy;Crit Rev Biotechnol.,2018

4. Monoclonal antibodies targeting CD38 in hematological malignancies and beyond;van de Donk;Immunol Rev.,2016

5. Rituximab in B-Cell hematologic malignancies: a review of 20 years of clinical experience;Salles;Adv Ther.,2017

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Polyphenols: Chemoprevention and therapeutic potentials in hematological malignancies;Frontiers in Nutrition;2022-10-26

2. CAR‐T cell therapy for patients with hematological malignancies. A systematic review;European Journal of Haematology;2022-09-18

3. Metabolic Factors Affecting Tumor Immunogenicity: What Is Happening at the Cellular Level?;International Journal of Molecular Sciences;2021-02-21

4. An Update on Immune Based Therapies in Acute Myeloid Leukemia: 2021 and Beyond!;Advances in Experimental Medicine and Biology;2021